A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The study drug LY2409021 is being evaluated as a possible treatment for diabetes. The primary
purpose of this study is to help answer the following research questions, and not to provide
treatment for diabetes :
- The safety of LY2409021 and any side effects that might be associated with it following
4 weeks of doses
- How long it takes the body to absorb and remove LY2409021 following dosing over 4 weeks
- How daily dosing of LY2409021 affects blood levels of sugar (glucose), insulin and other
naturally occurring substances before and after a meal
- How LY2409021 works when given with metformin
- How daily dosing of LY2409021 affects the cells that produce insulin